Company: BNBX
Filing Date: 2025-10-30
Form Type: S-1
Source: 0001104659-25-103871
Chunk: 25

Company: BNB PLUS CORP.
Filing Date: 2025-10-30
Form: S-1
Chunk 25
---
 other key management personnel, our executive management team’s ability to execute new operational initiatives, and certain matters outside of our control. In addition, we may incur certain costs as we pursue our growth, operational and management initiatives, and we may not meet anticipated implementation timetables or stay within budgeted costs. Also, our business strategies may change from time to time in light of our ability to implement our business initiatives, competitive pressures, economic uncertainties or developments, or other factors.

Stockholders may suffer substantial dilution if certain provisions in the May 2024 Series A Warrants are utilized.

On May 29, 2024, we closed on such date a public offering (the “May 2024 Offering”) of 12,308 units, with each such unit consisting of either (A) one share of our Common Stock, one series A common stock purchase warrant to purchase one share of our Common Stock (the “May 2024 Series A Warrants”) and one series B common stock purchase warrant to purchase one share of our Common Stock (the “May 2024 Series B Warrants” and, together with the May 2024 Series A Warrants, the “May 2024 Series Warrants”), or (B) one pre-funded warrant to purchase one share of our Common Stock, one Series A Warrant and one Series B Warrant, with Craig-Hallum Capital Group LLC (“Craig Hallum”) and Laidlaw & Company (UK) Ltd. (“Laidlaw”) as placement agents. In connection with the May 2024 Offering, we also issued placement agent warrants to purchase up to 615 shares of our Common Stock. As part of the May 2024 Offering, the Company entered into a Placement Agency Agreement, dated May 28, 2024, with Craig-Hallum and Laidlaw (the “May 2024 Placement Agency Agreement”). Each of the May 2024 Series Warrants had an original exercise price of $1.99 per share of Common Stock.

In addition, and subject to certain exemptions, the May 2024 Series A Warrants provide for an adjustment to the exercise price and number of shares underlying the May 2024 Series A Warrants if we sell, enter into an agreement to sell, or grant any option to purchase, or sell, enter into an agreement to sell, or grant any right to reprice (excluding Exempt Issuances, as defined in the May 2024 Placement Agency Agreement), or otherwise dispose of or issue